| Mark G Wilson, MD | |
|
200 Village Dr, Greensburg, PA 15601-3783 | |
| (724) 837-9207 | |
| (724) 836-4274 |
| Full Name | Mark G Wilson |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 200 Village Dr, Greensburg, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588673123 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | MD030558E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark G Wilson, MD 200 Village Dr, Greensburg, PA 15601-3783 Ph: (724) 837-9207 | Mark G Wilson, MD 200 Village Dr, Greensburg, PA 15601-3783 Ph: (724) 837-9207 |
News Archive
A brain circuit that underlies feelings of stress and anxiety shows promise as a new therapeutic target for alcoholism, according to new studies by researchers at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health (NIH).
College can be some of the best years of a person's life. But it is also a critical time, a time when students need to be aware of their health and safety. For women, many on their own for the first time in their lives, developing the ability to safeguard their emotional and physical health is paramount.
Days after Afghanistan vaccinated more than 7 million children against polio, the world's top health official and Afghan President Hamid Karzai pledged to capitalize swiftly on the country's remarkable progress towards eradicating the disease.
Pregnancy could be a turning point for HIV-infected women, when they have the opportunity to manage their infection, prevent transmission to their new baby and enter a long-term pattern of maintenance of HIV care after giving birth-but most HIV-infected women aren't getting that chance.
Mycovia Pharmaceuticals, making its official debut as a company developing therapies in women's health and dermatology, today announced the initiation of two Phase 3 clinical trials called VIOLET to evaluate the safety and efficacy of its lead candidate, VT-1161, in patients with recurrent vulvovaginal candidiasis
› Verified 9 days ago
Larissa J Roberts, LAT, ATC, M.ED Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 410 Pellis Rd, Greensburg, PA 15601 Phone: 814-227-6720 |